News

News


28 Apr 2010
Derived from the works of Paul-Henri Lambert, Tony Hawkridge, Willem A. Hanekom Clinics in Chest Medicine, 2009, vol 3. (4) pp. 811-26 TB patients awaiting treatment in Dhaka, Bangladesh photo: Jad Davenport Only one vaccine against tuberculosis (TB) now exists, bacille Calmette Guérin (BCG) ,...
26 Apr 2010
This post originally appeared at http://www.news25.us/Global/story.asp?S=12380174 Purdue Chao Center Purdue drug maker closing its doors after 5 years Associated Press – April 27, 2010 4:14 AM ET WEST LAFAYETTE, Ind. (AP) – An Indiana drug maker that’s North America’s sole manufacturer of a...
26 Apr 2010
How much does the nose know about TB? In a post a few weeks ago , we highlighted HeroRats , African-pouch rats, and their use for TB diagnoses. As described in that article, these rats are trained to distinguish positive TB samples verses negative TB samples presumably due to the release of...
25 Apr 2010
Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia REGISTER NOW FOR: Open Forum 4: Key Issues in TB Drug Development August 18-19, 2010 | Addis Ababa, Ethiopia International Conference to address regulatory challenges to TB drug development in Africa. Don’t...
25 Apr 2010
Stop TB Partnership The latest issue no.10 of Stop-TB News Monitor, for the period, 23-26 April 2010, is available online at: http://stoptb.citizen-news.org/2010/04/cns-stop-tb-news-monitor-23-26-april.html CNS Stop-TB News Monitor provides a snapshot of five major news pieces on tuberculosis (TB)...
21 Apr 2010
Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. For more than half a century, Dr. Mitchison has been dedicated to discovering new treatments for tuberculosis. Recently...
19 Apr 2010
Despite the massive need for new TB drugs, the commercial viability of the TB drug market has long been viewed as questionable at best. Reports suggest that there is a substantial market that will grow year-over-year, though there is no firm conclusion about its commercial viability. The first...
19 Apr 2010
This article originally appeared in Clinical Infectious Diseases 2010;50:S260–S266 © 2010 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2010/5010S3-0026$15.00 DOI: 10.1086/651500 Mark Harrington is Executive Director of Treatment Action Group Tuberculosis (TB) and...
19 Apr 2010
UNAIDS is conducting a second-round assessment on the impact of the financial crisis on HIV treatment and prevention programmes. The first assessment was carried out in August 2009. Its findings were reflected in the report “Update on the impact of the economic crisis: HIV Prevention and Treatment...
19 Apr 2010
World Health Organization The World Health Organization’s Stop TB Department has published the fourth edition of Treatment of Tuberculosis: Guidelines. The guidelines contain a number of new recommendations, including a call to discontinue regimens based on just two months of rifampicin (2HRZE/6HE...
14 Apr 2010
Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. For more than half a century, Dr. Mitchison has been dedicated to discovering new treatments for tuberculosis. Recently...
12 Apr 2010
NYAS On April 6 th , the New York Academy of Sciences hosted a mini-symposium entitled ‘Tuberculosis: Novel Therapies through Knowledge of the Genetics of the Causative Agent.’ The five research scientists who presented were: William R. Jacobs, Jr . (Albert Einstein College of Medicine),...
12 Apr 2010
IJTLD The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union). The IJTLD is the reference for clinical research and epidemiological studies on tuberculosis. It is also the only peer-...
7 Apr 2010
In Memoriam: Karel De Beule Post provided by Dr. Beule’s colleagues at Tibotec. In memoriam: Karel De Beule, PharmD, MBA (July 8, 1958 – April 6, 2010) following an outstanding 24+ year career in the pharmaceutical industry; Karel will be remembered for his contributions to pharmaceutical...
7 Apr 2010
Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. Born on September 6, 1916, Dr. Mitchison has had a long career dedicated to treating tuberculosis. After qualifying in...

Pages